{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T22:46:07Z","timestamp":1761864367423,"version":"3.41.0"},"reference-count":21,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,1]]},"abstract":"<jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>Pediatric parapneumonic effusion\/ pleural empyema (PPE\/PE) is a severe infectious condition, and its management should be guided by local epidemiology and the patient\u2019s medical history. This survey aimed to determine the clinical and bacteriologic features of PPE\/PE in Japan.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>A nationwide retrospective questionnaire survey was conducted, targeting 159 pediatric specialist training medical facilities for inpatients \u226418 years of age who were admitted for PPE\/PE between January 2007 and December 2016.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>Valid responses were obtained from 122 facilities, and 96 patients were identified from 38 facilities. The median age (interquartile range) was 2.7 (0.8\u20137.8) years. Overall, 60 (63 %) patients were men and 49 (51%) had comorbidities. The causative bacteria were identified in 59% of patients by culture except in one case identified using PCR. <jats:italic toggle=\"yes\">Streptococcus pyogenes<\/jats:italic> (16%), <jats:italic toggle=\"yes\">Staphylococcus aureus<\/jats:italic> (14%) and <jats:italic toggle=\"yes\">Streptococcus pneumoniae<\/jats:italic> (13%) were the major pathogens. Carbapenems were administered to 34% of patients without comorbidities. Chest tube drainage was performed in 71%, intrapleural fibrinolytic therapy in 9.4%, surgery in 25% and mechanical ventilation in 29% of the patients. Five patients (5.2%) had complications and one (1.1%) had sequelae, but all patients (100%) survived.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>This is first report of a nationwide survey pertaining to pediatric PPE\/PE in Japan. We found that the etiology showed a different trend from that reported in other countries. It is worrisome that molecular methods were rarely used for pathogenic diagnosis and carbapenems were overused. Thus, it is imperative to establish clinical guidelines for PPE\/PE in Japan.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/inf.0000000000003353","type":"journal-article","created":{"date-parts":[[2021,12,4]],"date-time":"2021-12-04T03:00:20Z","timestamp":1638586820000},"page":"20-23","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":7,"title":["Pediatric Parapneumonic Effusion\/Pleural Empyema in Japan"],"prefix":"10.1097","volume":"41","author":[{"given":"Tadashi","family":"Hoshino","sequence":"first","affiliation":[{"name":"Division of Infectious Diseases, Chiba Children\u2019s Hospital, Chiba-city, Chiba, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daisuke","family":"Nishima","sequence":"additional","affiliation":[{"name":"Division of Allergy and Pulmonology, Fukuoka Children\u2019s Hospital, Kashiiteriha, Higashi-ku, Fukuoka, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mayumi","family":"Enseki","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Tokai University Hospital, Isehara-city, Kanagawa, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoki","family":"Umehara","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, St Luke\u2019s Hospital, Akashi-cho, Chuo-ku, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chie","family":"Fukasawa","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Chiba Children\u2019s Hospital, Chiba-city, Chiba, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naruhiko","family":"Ishiwada","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Medical Mycology Research Center, Chiba University, Chiba-city, Chiba, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2021,12,8]]},"reference":[{"key":"R1-20250615","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/apa.12426","article-title":"Seventeen-year study shows rise in parapneumonic effusion and empyema with higher treatment failure after chest tube drainage.","volume":"103","author":"Yu","year":"2014","journal-title":"Acta Paediatr"},{"key":"R2-20250615","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1111\/j.1651-2227.2011.02290.x","article-title":"Parapneumonic empyema in children before the era of pneumococcal vaccination.","volume":"100","author":"Niemi","year":"2011","journal-title":"Acta Paediatr"},{"key":"R3-20250615","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1097\/INF.0b013e3182002d14","article-title":"Molecular analysis improves pathogen identification and epidemiologic study of pediatric parapneumonic empyema.","volume":"30","author":"Blaschke","year":"2011","journal-title":"Pediatr Infect Dis J"},{"key":"R4-20250615","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1097\/INF.0b013e31828637b1","article-title":"Etiology of empyema thoracis and parapneumonic pleural effusion in Taiwanese children and adolescents younger than 18 years of age.","volume":"32","author":"Lin","year":"2013","journal-title":"Pediatr Infect Dis J"},{"key":"R5-20250615","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1086\/650573","article-title":"Increasing incidence of empyema complicating childhood community-acquired pneumonia in the United States.","volume":"50","author":"Grijalva","year":"2010","journal-title":"Clin Infect Dis"},{"key":"R6-20250615","doi-asserted-by":"crossref","first-page":"6243","DOI":"10.1016\/j.vaccine.2016.10.062","article-title":"Changes in empyema among U.S. children in the pneumococcal conjugate vaccine era.","volume":"34","author":"Wiese","year":"2016","journal-title":"Vaccine"},{"key":"R7-20250615","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/j.cmi.2018.10.020","article-title":"Changes in the incidence and bacterial aetiology of paediatric parapneumonic pleural effusions\/empyema in Germany, 2010-2017: a nationwide surveillance study.","volume":"25","author":"Liese","year":"2019","journal-title":"Clin Microbiol Infect"},{"key":"R8-20250615","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.jinf.2015.06.011","article-title":"Additive impact of pneumococcal conjugate vaccines on pneumonia and empyema hospital admissions in England.","volume":"71","author":"Saxena","year":"2015","journal-title":"J Infect"},{"key":"R9-20250615","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1007\/s13665-017-0161-4","article-title":"Empyema in children: update of aetiology, diagnosis and management approaches.","volume":"6","author":"Zampoli","year":"2017","journal-title":"Curr Pulmono Rep"},{"key":"R10-20250615","doi-asserted-by":"crossref","first-page":"e91","DOI":"10.1017\/S0950268820000813","article-title":"Epidemiology of hospitalised paediatric community-acquired pneumonia and bacterial pneumonia following the introduction of 13-valent pneumococcal conjugate vaccine in the national immunisation programme in Japan.","volume":"148","author":"Takeuchi","year":"2020","journal-title":"Epidemiol Infect"},{"key":"R11-20250615","doi-asserted-by":"crossref","first-page":"6054","DOI":"10.1016\/j.vaccine.2015.07.069","article-title":"Nationwide population-based surveillance of invasive pneumococcal disease in Japanese children: effects of the seven-valent pneumococcal conjugate vaccine.","volume":"33","author":"Suga","year":"2015","journal-title":"Vaccine"},{"key":"R13-20250615","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.rmed.2016.05.009","article-title":"Etiology of parapneumonic effusion and pleural empyema in children. The role of conventional and molecular microbiological tests.","volume":"116","author":"Krenke","year":"2016","journal-title":"Respir Med"},{"key":"R14-20250615","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1155\/2014\/757963","article-title":"Real-time polymerase chain reaction for microbiological diagnosis of parapneumonic effusions in Canadian children.","volume":"25","author":"Pernica","year":"2014","journal-title":"Can J Infect Dis Med Microbiol"},{"key":"R15-20250615","doi-asserted-by":"crossref","first-page":"i1","DOI":"10.1136\/thx.2004.030676","article-title":"BTS guidelines for the management of pleural infection in children.","volume":"60 Suppl 1","author":"Balfour-Lynn","year":"2005","journal-title":"Thorax"},{"key":"R16-20250615","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1097\/INF.0000000000003036","article-title":"Effect of Prehospital Antibiotic Therapy on Clinical Outcome and Pathogen Detection in Children With Parapneumonic Pleural Effusion\/Pleural Empyema.","volume":"40","author":"Forster","year":"2021","journal-title":"Pediatr Infect Dis J"},{"key":"R17-20250615","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1093\/jpids\/piy103","article-title":"Change in bacterial causes of community-acquired parapneumonic effusion and pleural empyema in children 6 years after 13-valent pneumococcal conjugate vaccine implementation.","volume":"8","author":"Madhi","year":"2019","journal-title":"J Pediatric Infect Dis Soc"},{"key":"R18-20250615","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.diagmicrobio.2011.09.025","article-title":"Diagnosis of pneumococcal empyema using immunochromatographic test on pleural fluid and serotype distribution in Korean children.","volume":"72","author":"Lee","year":"2012","journal-title":"Diagn Microbiol Infect Dis"},{"key":"R19-20250615","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1097\/PEC.0b013e318289e810","article-title":"Pediatric parapneumonic empyema: risk factors, clinical characteristics, microbiology, and management.","volume":"29","author":"Grisaru-Soen","year":"2013","journal-title":"Pediatr Emerg Care"},{"key":"R20-20250615","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1136\/thorax.57.4.343","article-title":"Randomised trial of intrapleural urokinase in the treatment of childhood empyema.","volume":"57","author":"Thomson","year":"2002","journal-title":"Thorax"},{"key":"R21-20250615","doi-asserted-by":"crossref","first-page":"e1301","DOI":"10.1542\/peds.2013-3935","article-title":"Urokinase versus VATS for treatment of empyema: a randomized multicenter clinical trial.","volume":"134","author":"Marhuenda","year":"2014","journal-title":"Pediatrics"},{"key":"R22-20250615","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1164\/rccm.200601-027OC","article-title":"Comparison of urokinase and video-assisted thoracoscopic surgery for treatment of childhood empyema.","volume":"174","author":"Sonnappa","year":"2006","journal-title":"Am J Respir Crit Care Med"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000003353","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,15]],"date-time":"2025-06-15T16:01:08Z","timestamp":1750003268000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000003353"}},"subtitle":["A Nationwide Survey"],"short-title":[],"issued":{"date-parts":[[2021,12,8]]},"references-count":21,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/inf.0000000000003353","relation":{},"ISSN":["0891-3668"],"issn-type":[{"type":"print","value":"0891-3668"}],"subject":[],"published":{"date-parts":[[2021,12,8]]}}}